Disrupted Healthcare – Global Deals and Investments – 38 Transactions This Week

VC Deals (14 deals, $198M)

Homology Medicines Inc., a Lexington, Mass.-based gene editing and gene therapy company focused on developing treatments for patients with rare diseases, has raised $43.5 million in Series A funding. 5AM VenturesandARCH Venture Partners co-led the round, and were joined by Temasek and Deerfield Management

Sienna Biopharmaceuticals Inc., a Westlake Village, Calif.-based aesthetics and medical dermatology startup, has raised $34 million in Series A funding.ARCH Venture Partners led the round, and was joined by Altitude Life Science Ventures, Partner Fund Management and Venvest Capital

Envera Health, a Richmond, Va.-based provider of consumer engagement solutions for healthcare providers, has raised $14 million in new VC funding.Harbert Venture Partners and Noro-Moseley Partnersco-led the round, and were joined by New Richmond Ventures

IDEAYA Biosciences Inc., a California-based developer of personalized synthetic lethality medicines, has raised $46 million in Series A funding. Backers include 5AM Ventures, Canaan Partners, Celgene, WuXi Healthcare Ventures, Novartis Institute of Biomedical Research and Alexandria Real Estate

Sirnaomics Inc., a Gaithersburg, Md.-based developer of RNAi therapeutics, has raised $10 million in Series B funding led by Hong Kong-based Value Measured Investment Ltd

CloudHealth Technologies, a Boston-based provider of cloud service management solutions, has raised $20 million in Series C funding. Sapphire Ventures led the round, and was joined by Scale Venture Partners, .406 Ventures and Sigma Prime Ventures

Somnoware Healthcare Systems, a Charlotte, N.C.-based cloud platform for sleep wellness and sleep disorder management, has raised $9 million in Series A funding. TransLink Capital led the round, and was joined by the World Innovation Lab

WeCounsel Solutions LLC, a Chattanooga, Tenn.-based telemedicine software startup, has raised $3.5 million in Series A funding. Backers include Longmeadow Capital Partners, Point Judith Capital and CVH Holdings

ACT Genomics, a Taipei-based provider of cancer molecular information solutions, has raised $12.5 million in Series B funding. Hotung Group and CDIB Capital Management co-led the round, and were joined by return backers Eminent II VC, Hua Nan Venture Capital, President International Development and UMC Capital

Blueberry Therapeutics, a UK-based developer of topical fungal infection therapies, has raised £3 million in new VC funding. GM&C Life Sciences Fund(managed by Catapult Ventures) led the round, and was joined by InClin Investments

DocsApp, a year-old, Bangalore, India-based medical consultation app, has raised $1.2 million in seed funding, including from Rebright Partners and angel investors Anand Rajaraman and Venky Harinarayan #healthtechasia

Parasail Health, a two-year-old, Palo Alto, Ca.-based company that provides term loans to help individuals cover their out of pocket medical expenses, has raised an undisclosed amount of seed funding round from Peter Thieland Montage Ventures

ThingsMeet Solutions Pvt. Ltd, which owns soon-to-launch healthcare appPrescribez, has raised an undisclosed amount in seed funding from high net-worth individual and angel investor Ankush Mehta #healthtechasia

MyDentistChoice, a Hyderabad based e-commerce platform for dental products, has raised $150,000 in seed investment from a US-based investor, it said in a statement #healthtechasia

PE Deals (9 deals)

Anne Arundel Dermatology Management, a Severna Park, Md.-based dermatology practice network owned by New MainStream Capital, has acquired Rockville, Md.-based Montgomery Dermatology Associates LLC. No financial terms were disclosed

Concordia Healthcare Corp. (TSX: CXR), a Canadian pharma company with a current market cap of C$1.86 billion, has hired Greenhill & Co. to solicit potential buyers, according to Bloomberg. Apollo Global Management and TPG Capital reportedly are among those that have been contacted, whileBloombergpreviously reported that the company had held preliminary takeover talks with The Blackstone Group

Kohlberg & Co. has acquired Amendia, a Marietta, Ga.-based maker of medical devices used in spinal surgical procedures. No financial terms were disclosed

Epic Health Services Inc., a Dallas-based portfolio company of Webster Capital, has acquired Care Resources, a Baltimore-based provider of pediatric therapy and early intervention services for children with special needs, plus staffing of education teachers and nurses to schools. No financial terms were disclosed. The seller was ResCare, a portfolio company of Onex Corp

Spinal Simplicity, an Overland Park, Kansas-based developer of medical devices for comkplex spinal surgeries, has raised an undisclosed amount of equity funding from Nueterra Capital

Webster Capital has acquired Healthcare Associates of Texas, a physician practice management company that provides services to Healthcare Associates of Irving, a full-service primary care practice in Dallas. No financial terms were disclosed

Atos Medical,a Swedish medical device company owned by EQT Partners, has short-listed a group of private equity firms as prospective buyers, according toReuters. The story does not disclose those firms that reached the second rounds, but does say that indicative bids were made by such groups as Astorg Partners, Montagu Private Equity, Hellman & Friedman, PAI Partners and Warburg Pincus. Atos Medical could be valued at around $1.5 billion

Spanos Barber Jesse & Co. has sponsored a recapitalization of Stat Health Management LLC, a Long Island, N.Y.-based urgent care company. No financial terms were disclosed

Pyramid Healthcare Inc., a Cleasrwater, Fla.-based portfolio company ofClearview Capital, has acquired two providers of outpatient substance abuse treatment services in Pennsylvaia: Mazzitti & Sullivan and Quest Services. No financial terms were disclosed

IPO Deals (5 deals)

Cotiviti Holdings Inc., an Atlanta-based provider of payment accuracy software for the healthcare and retail sectors, has filed for a $100 million IPO. It plans to trade on the NYSE under ticker symbol COTV, with Goldman Sachs and J.P. Morgan serving as lead underwriters. The company reports nearly $14 million of net income in 2015 on $541 million in revenue, compared to a $26 million loss on $441 million in revenue for 2014. Citiviti is owned by Advent International

Cleopatra Hospital Co., an Egyptian hospital group owned by Abraaj Group, is preparing a local IPO that could value the company at upwards of $300 million

Viamet Pharmaceuticals Holdings, a Durham, N.C.-based developer of inhibitors of validated metalloenzymes, has set its IPO terms to 5.7 million shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $389 million, were it to price in the middle of range. The company previously filed for a $75 million floatation in 2014, but withdrew its offering later that year. It plans to trade on the Nasdaq under ticker symbol VMET, with Morgan Stanley and Goldman Sachs serving as lead underwriters. Viamet has raised over $150 million in VC funding from firms like Novartis Bioventures (12.9% pre-IPO stake), Lilly Ventures (11.3%), Hatteras Venture Partners (7.8%) and Intersouth Partners (6.3%)

Philips (Amsterdam: PHIA) is planning to sell up to 25% of its lighting business via an Amsterdam IPO

Intellia Therapeutics, a Cambridge, Mass.-based gene-editing company focused on the development of medicines using CRISPR/Cas9 technology, raised $108 million in its IPO. The company priced 6 million shares at $18 per share, compared to earlier plans to offer 5 million shares at $16-$18 per share. The pre-revenue company has an initial market cap of around $617 million, and will trade on the Nasdaq under ticker symbol NTLA. Credit Suisse, Jefferies and Leerink Partners served as lead underwriters. Intellia had raised in VC funding, from firms like Novartis (20.3% pre-IPO stake), Atlas Venture (17%), OrbiMed Advisors (9.3%), Fidelity (7.1%), Janus Capital Management, Foresite Capital, Sectoral Asset Management and EcoR1 Capital

Other Deals (10 deals)

CCMP Capital is exploring a sale of Jamieson Laboratories, a Canadian vitamin maker that could be valued at around $1 billion, according to the WSJ. Nomura and Houlihan Lokey are managing the process

Biogen (Nasdaq: BIIB) announced plans for a tax-free spinout of its hemophilia drug business

DAS Health, a Tampa, Fla.-based provider of health IT and management services, has acquired the electronic health records and practice management business of Mobile, Ala.-based Jackson Key Practice Solutions. No financial terms were disclosed

GNC (NYSE: GNC), a Pittsburgh-based retailer of nutritional supplements and other wellness products, said that it has hired Goldman Sachs to explore “strategic and financial alternatives,” including a possible sale of the company. GNC has a current market cap of around $1.78 billion, and the announcement came after an underwhelming earnings report

Hellman & Friedman announced an agreement to acquire MultiPlan, a New York-based healthcare services provider, from Starr Investment Holdings and Partners Group (each of which will retain minority equity stakes). No financial terms were disclosed, but earlier media reports suggested a price-tag of around $7.5 billion (including assumed debt)

 Clorox Co. (NYSE: CLX) has acquired Renew Life, a Palm Harbor, Fla.-based maker of probiotics and other digestive care supplements, from Swander Pace Capital. The deal was valued at $290 million

Pfizer (NYSE: PFE) has approached Medivation (Nasdaq: MDVN), a San Francisco-based prostate cancer drug-maker, about a rival bid to an existing $9.3 billion cash takeover offer from France’s Sanofi

The Carlyle Group has hired Natixis to find a buyer for French orthopedic implant maker Groupe Marle, according to the WSJ. Marle generated around €24 million in EBITDA for its last fiscal year

Aemetis Inc. (Nasdaq: AMTX) has agreed to acquire Edeniq, a Visalia, Calif.-based company that has developed a process for converting cellulosic biomass to industrial sugars, for nearly $23 million in cash and stock (including an earn-out). Edeniq had raised around $100 million in VC funding since 2008, from firms like Kleiner Perkins Caulfield & Byers, DFJ, Angeleno Group, The Westly Group and I2BF Global Ventures. It also reports $6 million in 2015 EBITDA on around $20 million in revenue

Brecksville, Ohio-based healthcare services company MedData (not to be confused with Medidata) has acquired Columbus, Ohio-based patient engagement company Duet Health

Sources: Term Sheet, Financial Times, StrictlyVC, TechinAsia, CrunchBase, TechCrunch, Bloomberg, MobiHealthNews

The Propell Group

#healthtech #asia